| Ms Pamela Joy D Abantao, PT | |
|
42 Amherstdale Rd, Amherst, NY 14226-4410 | |
| (347) 226-8059 | |
| Not Available |
| Full Name | Ms Pamela Joy D Abantao |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 42 Amherstdale Rd, Amherst, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023876869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 04031401 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Pamela Joy D Abantao, PT 42 Amherstdale Rd, Amherst, NY 14226-4410 Ph: (347) 226-8059 | Ms Pamela Joy D Abantao, PT 42 Amherstdale Rd, Amherst, NY 14226-4410 Ph: (347) 226-8059 |
News Archive
Social media captures demographic data on physical activity by using Twitter and artificial intelligence (AI), a new study shows.
An increase in prescription drug fraud has caused doctors and hospital administrators to call for legislation to provide stronger safeguards. They say that such measures are especially important to protect government programs such as Medicaid and that heath reform proposals should increase coverage for drug treatment and rehabilitation. They note that prescription drug abuse and Medicaid fraud are especially sensitive issues in rural areas that struggle to attract providers.
Community Health Systems, Inc., announced today that on March 7, 2012, its wholly-owned subsidiary, CHS/Community Health Systems, Inc., priced an offering of $1.0 billion aggregate principal amount 8.00% senior notes due 2019 at an issue price of approximately 102.5%.
Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.
Among patients with juvenile idiopathic arthritis (JIA) who initiated treatment with the drug etanercept, one-third achieved an excellent response, and this response was associated with low measures of disability at study entry, younger age at the onset of JIA, and fewer disease-modifying antirheumatic drugs used before initiating etanercept, according to a study appearing in JAMA.
› Verified 9 days ago
Donna A Gulick, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3970 Harlem Rd, Amherst, NY 14226 Phone: 716-839-3705 Fax: 716-839-2347 | |
Jamie Marie Whitenight, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3925 Sheridan Dr, Suite 100, Amherst, NY 14226 Phone: 716-250-9999 Fax: 250-250-4177 | |
Justin Patrick Nelson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4498 Main St. Suite 24, Amherst, NY 14226 Phone: 716-839-1550 Fax: 716-839-1696 | |
Mr. Ruddi Edward Barbolini, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4575 Main Street, Amherst, NY 14226 Phone: 716-839-2881 Fax: 716-839-2882 | |
Phoenix Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4498 Main Street, Suite #24, Amherst, NY 14226 Phone: 716-839-1550 Fax: 716-839-1696 | |
Philip Werner Sorensen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3925 Sheridan Dr, Amherst, NY 14226 Phone: 716-250-9999 |